APA

Iglesias D. A., Yates M. S., van der Hoeven D., Rodkey T. L., Zhang Q., Co N. N., Burzawa J., Chigurupati S., Celestino J., Bowser J., Broaddus R., Hancock J. F., Schmandt R. & Lu K. H. (20140804). Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy. : Molecular cancer therapeutics.

Chicago

Iglesias David A, Yates Melinda S, van der Hoeven Dharini, Rodkey Travis L, Zhang Qian, Co Ngai Na, Burzawa Jennifer, Chigurupati Sravanthi, Celestino Joseph, Bowser Jessica, Broaddus Russell, Hancock John F, Schmandt Rosemarie and Lu Karen H. 20140804. Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy. : Molecular cancer therapeutics.

Harvard

Iglesias D. A., Yates M. S., van der Hoeven D., Rodkey T. L., Zhang Q., Co N. N., Burzawa J., Chigurupati S., Celestino J., Bowser J., Broaddus R., Hancock J. F., Schmandt R. and Lu K. H. (20140804). Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy. : Molecular cancer therapeutics.

MLA

Iglesias David A, Yates Melinda S, van der Hoeven Dharini, Rodkey Travis L, Zhang Qian, Co Ngai Na, Burzawa Jennifer, Chigurupati Sravanthi, Celestino Joseph, Bowser Jessica, Broaddus Russell, Hancock John F, Schmandt Rosemarie and Lu Karen H. Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy. : Molecular cancer therapeutics. 20140804.